Inspection Record

Hikal Limited — FDA 483 Findings

US FDAInspected 2025-02-07Published 2026-04-03 5 findingsOther quality systemComputer system validationEquipment and facility

Inspectors Marcellinus D DordunooThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

Back-up data is not appropriately protected from unauthorized access, manipulation or deletion.

2Computer system validation

Incidents related to computerized systems that could affect the quality of intermediates or APIs are not recorded and investigated.

3Equipment and facility

Appropriate ~aintenance and calibration ofcritical equipment is not performed.

4Other quality system

Out-Of-Specification (OOS) results are routinely invalidated, without sufficient supporting evidence or scientific justification ofthe root cause.

5Other quality system

Written procedures are deficient specifically A.

About this record

Extracted automatically from the document US FDA published on 2026-04-03. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Hikal Limited company profile — full history US FDA documents, 2026 Go to Findings search